136 related articles for article (PubMed ID: 22703300)
1. Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.
Nguyen JP; Frost CD; Lane ML; Skelton WP; Skelton M; Vesely DL
Eur J Clin Invest; 2012 Oct; 42(10):1061-7. PubMed ID: 22703300
[TBL] [Abstract][Full Text] [Related]
2. Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells.
Manimala NJ; Frost CD; Lane ML; Higuera M; Beg R; Vesely DL
Eur J Clin Invest; 2013 Nov; 43(11):1156-62. PubMed ID: 23992401
[TBL] [Abstract][Full Text] [Related]
3. Central role of β-catenin in anticancer effects of cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Jun; 33(6):2409-14. PubMed ID: 23749889
[TBL] [Abstract][Full Text] [Related]
4. Potent selective inhibition of STAT 3 versus STAT 1 by cardiac hormones.
Lane ML; Frost CD; Nguyen JP; Skelton WP; Skelton M; Vesely DL
Mol Cell Biochem; 2012 Dec; 371(1-2):209-15. PubMed ID: 22965761
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of AKT in human pancreatic, renal and colorectal cancer cells by four cardiac hormones.
Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2013 Mar; 33(3):785-90. PubMed ID: 23482745
[TBL] [Abstract][Full Text] [Related]
6. Five cardiac hormones decrease the number of human small-cell lung cancer cells.
Vesely BA; Song S; Sanchez-Ramos J; Fitz SR; Alli AA; Solivan SM; Gower WR; Vesely DL
Eur J Clin Invest; 2005 Jun; 35(6):388-98. PubMed ID: 15948900
[TBL] [Abstract][Full Text] [Related]
7. Cardiac hormones inhibit proliferation of pancreatic cancer but not normal cells.
Skelton WP; Pi G; Lenz A; Sun Y; Vesely DL
Eur J Clin Invest; 2010 Aug; 40(8):706-12. PubMed ID: 20546014
[TBL] [Abstract][Full Text] [Related]
8. Cardiac hormones are c-Jun-N-terminal kinase 2-inhibiting peptides.
Lane ML; Santana O; Frost CD; Nguyen J; Guerrero J; Skelton WP; Skelton M; Vesely DL
Anticancer Res; 2012 Mar; 32(3):721-5. PubMed ID: 22399583
[TBL] [Abstract][Full Text] [Related]
9. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones.
Vesely DL; Eichelbaum EJ; Sun Y; Alli AA; Vesely BA; Luther SL; Gower WR
In Vivo; 2007; 21(3):445-51. PubMed ID: 17591353
[TBL] [Abstract][Full Text] [Related]
10. Long-acting natriuretic peptide, vessel dilator, and kaliuretic peptide enhance the urinary excretion rate of beta2-microglobulin.
Vesely DL; Perez-Lamboy GI; Schocken DD
Metabolism; 2000 Dec; 49(12):1592-7. PubMed ID: 11145122
[TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptides: anticancer agents.
Vesely DL
J Investig Med; 2005 Nov; 53(7):360-5. PubMed ID: 16297362
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic approach for cancer using four cardiovascular hormones.
Vesely DL; Clark LC; Garces AH; McAfee QW; Soto J; Gower WR
Eur J Clin Invest; 2004 Oct; 34(10):674-82. PubMed ID: 15473892
[TBL] [Abstract][Full Text] [Related]
13. Cardiac hormones are potent inhibitors of secreted frizzled-related protein-3 in human cancer cells.
Skelton WP; Skelton M; Vesely DL
Exp Ther Med; 2013 Feb; 5(2):475-478. PubMed ID: 23408665
[TBL] [Abstract][Full Text] [Related]
14. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
Vesely DL
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
[TBL] [Abstract][Full Text] [Related]
15. Four cardiac hormones eliminate up to two-thirds of human breast cancers in athymic mice.
Vesely DL; Vesely BA; Eichelbaum EJ; Sun Y; Alli AA; Gower WR
In Vivo; 2007; 21(6):973-8. PubMed ID: 18210743
[TBL] [Abstract][Full Text] [Related]
16. Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.
Lenz A; Sun Y; Eichelbaum EJ; Skelton WP; Pi G; Vesely DL
Eur J Clin Invest; 2010 Mar; 40(3):242-9. PubMed ID: 20415699
[TBL] [Abstract][Full Text] [Related]
17. Four cardiac hormones cause death of human cancer cells but not of healthy cells.
Skelton WP; Pi GE; Vesely DL
Anticancer Res; 2011 Feb; 31(2):395-402. PubMed ID: 21378317
[TBL] [Abstract][Full Text] [Related]
18. Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells.
Sun Y; Eichelbaum EJ; Wang H; Vesely DL
Anticancer Res; 2007; 27(3B):1387-92. PubMed ID: 17595752
[TBL] [Abstract][Full Text] [Related]
19. Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells.
Vesely BA; Fitz SR; Gower WR; Vesely DL
Cancer Lett; 2006 Feb; 233(2):226-31. PubMed ID: 15893414
[TBL] [Abstract][Full Text] [Related]
20. Cardiac natriuretic peptides: hormones with anticancer effects that localize to nucleus, cytoplasm, endothelium, and fibroblasts of human cancers.
Saba SR; Vesely DL
Histol Histopathol; 2006 Jul; 21(7):775-83. PubMed ID: 16598676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
